1. Association between oral contraceptives with lipid profile: results from Hoveyzeh cohort study (HCS).
- Author
-
Hashemi, Seyed Jalal, Khezri, Rozhan, Saki, Nader, Nasehi, Nahal, Hosseini, Seyed Ahmad, Harizi, Mahmood, and Rahimi, Zahra
- Subjects
- *
ORAL contraceptives , *LIPID metabolism , *DISEASE risk factors , *LIPIDS , *COHORT analysis - Abstract
Background: Oral contraceptives (OCs) affect lipid metabolism, which can cause hyperlipidemia, a risk factor for cardiovascular diseases. The study was designed to evaluate the possible changes in lipid profile due to using OCs. Methods: A cross-sectional study was conducted from April 2016 to August 2018 among women from the baseline phase Hoveyzeh cohort study (HCS). Sociodemographic data, anthropometric measurements, physical activity, and biochemical blood tests were measured for every participant. Multiple logistic regression was used to adjust the potential confounders. Results: Among 2272 participants, 1549 women were OC users, and 723 women were non-user OCs. The mean lipid profile levels were higher in OC users than in non-user OCs. Odds of abnormal Total cholesterol (TC) in OC users were significantly higher than those of non-users OCs [OR = 1.29 (95% CI;1.05 to 1.58)]. Also, the Odds of abnormal low-density lipoprotein (LDL) in OC users was 12% higher than in non-user OCs. However, no significant relationship between abnormal LDL with Oral Contraceptive Pills (OCPs) was observed. Conclusions: The mean lipid profile was higher in OC users compared to non-user OCs. This finding highlights the need for public health strategies to prevent and detect hyperlipidemia in user OCs. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF